Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 6, 2014 - Issue
Submit an article Journal homepage
652
Views
14
CrossRef citations to date
0
Altmetric
Review

Palbociclib: an evidence-based review of its potential in the treatment of breast cancer

Karen A CadooBreast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY, USA
,
Ayca GucalpBreast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY, USA
&
Tiffany A TrainaBreast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY, USA
Pages 123-133 | Published online: 04 Aug 2014

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Michael J. Thwaites, Matthew J. Cecchini, Daniel T. Passos, Ian Welch & Frederick A. Dick. (2017) Interchangeable Roles for E2F Transcriptional Repression by the Retinoblastoma Protein and p27KIP1–Cyclin-Dependent Kinase Regulation in Cell Cycle Control and Tumor Suppression. Molecular and Cellular Biology 37:2.
Read now
Ciara C. O’Sullivan. (2016) CDK4/6 inhibitors for the treatment of advanced hormone receptor positive breast cancer and beyond: 2016 update. Expert Opinion on Pharmacotherapy 17:12, pages 1657-1667.
Read now
Di Wu, Bing Han, Liang Guo & Zhimin Fan. (2016) Molecular mechanisms associated with breast cancer based on integrated gene expression profiling by bioinformatics analysis. Journal of Obstetrics and Gynaecology 36:5, pages 615-621.
Read now
Priyank Patel, Benedikt Asbach, Elina Shteyn, Cindy Gomez, Alexander Coltoff, Sadia Bhuyan, Angela L. Tyner, Ralf Wagner & Stacy W. Blain. (2015) Brk/Protein Tyrosine Kinase 6 Phosphorylates p27KIP1, Regulating the Activity of Cyclin D–Cyclin-Dependent Kinase 4. Molecular and Cellular Biology 35:9, pages 1506-1522.
Read now

Articles from other publishers (10)

Hua Zhang, Shu Yan, Yan Zhan, Sheng Ma, Yicong Bian, Shaorong Li, Junjun Tian, Guangze Li, Dafang Zhong, Xingxing Diao & Liyan Miao. (2023) A mass balance study of [14C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans. Frontiers in Pharmacology 14.
Crossref
K. S. Grechukhina, K. A. Vorontsova, D. A. Filonenko, P. S. Tyutyunnik, V. V. Shchadrova, V. V. Glebovskaya & L. G. Zhukova. (2022) Role of ribociclib in treatment of luminal Her-2-negative mBC with CNS metastases. Meditsinskiy sovet = Medical Council:22, pages 42-51.
Crossref
Franziska Kellers, Aurélie Fernandez, Björn Konukiewitz, Mario Schindeldecker, Katrin E. Tagscherer, Achim Heintz, Moritz Jesinghaus, Wilfried Roth & Sebastian Foersch. (2022) Senescence-Associated Molecules and Tumor-Immune-Interactions as Prognostic Biomarkers in Colorectal Cancer. Frontiers in Medicine 9.
Crossref
Irene Galiana, Beatriz Lozano-Torres, Mónica Sancho, María Alfonso, Andrea Bernardos, Viviana Bisbal, Manuel Serrano, Ramón Martínez-Máñez & Mar Orzáez. (2020) Preclinical antitumor efficacy of senescence-inducing chemotherapy combined with a nanoSenolytic. Journal of Controlled Release 323, pages 624-634.
Crossref
Nicholas B. Figura, Thrisha K. Potluri, Homan Mohammadi, Daniel E. Oliver, John A. Arrington, Timothy J. Robinson, Arnold B. Etame, Nam D. Tran, James K. Liu, Hatem Soliman, Peter A. Forsyth, Solmaz Sahebjam, H. Michael Yu, Hyo S. Han & Kamran A. Ahmed. (2019) CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases. Journal of Neuro-Oncology 144:3, pages 583-589.
Crossref
Marion A.A. Libouban, Jeroen A.D.M. de Roos, Joost C.M. Uitdehaag, Nicole Willemsen-Seegers, Sara Mainardi, Jelle Dylus, Jos de Man, Bastiaan Tops, Jules P.P. Meijerink, Zuzana Storchová, Rogier C. Buijsman, René H. Medema & Guido J.R. Zaman. (2017) Stable aneuploid tumors cells are more sensitive to TTK inhibition than chromosomally unstable cell lines. Oncotarget 8:24, pages 38309-38325.
Crossref
Jacquelyn J. Bower, Leah D. Vance, Matthew Psioda, Stephanie L. Smith-Roe, Dennis A. Simpson, Joseph G. Ibrahim, Katherine A. Hoadley, Charles M. Perou & William K. Kaufmann. (2017) Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells. npj Breast Cancer 3:1.
Crossref
Nicholas J. Dyson. (2016) RB1 : a prototype tumor suppressor and an enigma . Genes & Development 30:13, pages 1492-1502.
Crossref
Lisette B. W. Schröder & Kerrie L. McDonald. (2015) CDK4/6 Inhibitor PD0332991 in Glioblastoma Treatment: Does It Have a Future?. Frontiers in Oncology 5.
Crossref
Kenji Tamura. (2015) Development of cell-cycle checkpoint therapy for solid tumors. Japanese Journal of Clinical Oncology, pages hyv131.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.